Company profile: InterVene
1.1 - Company Overview
Company description
- Provider of minimally invasive medical devices and therapies for chronic venous disease, particularly deep vein valve failure. The company's BlueLeafβ’ Endovenous Valve Formation System offers a non-implantable solution to address severe venous conditions in the legs, aiming to improve patient outcomes.
Products and services
π
Key contacts
π
π
Financial details
π
1.2 - Competitors and similar companies to InterVene
Cardioxyl
HQ: United States
Website
- Description: Provider of clinical-stage biopharmaceutical research and development focused on discovering, developing and commercializing novel therapies for cardiovascular disease, targeting areas where current treatments do not exist, are ineffective or inadequate.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Cardioxyl company profile β
Corvia Medical
HQ: United States
Website
- Description: Provider of transcatheter structural heart devices for heart failure, including the Corvia Atrial Shunt (InterAtrial Shunt Device) designed to treat diastolic heart failure/HFpEF by reducing pressures in the heart and lungs, supported by clinical evidence and the RESPONDER-HF clinical study assessing efficacy in patients with EF β₯40%.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Corvia Medical company profile β
Procyrion
HQ: United States
Website
- Description: Provider of catheter-based circulatory support technologies, including Aortix, a catheter-deployed pump that augments blood flow from the aortic arch to the lower aorta, reduces aortic root pressure, and increases renal perfusion to support patients with acute decompensated heart failure, renal support needs, and chronic heart failure.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Procyrion company profile β
Excision Medical
HQ: United States
Website
- Description: Provider of tools for TAVR procedures focused on safe, reliable leaflet modification and excision, device steering, and temporary hemodynamic support. Offerings include the Leaflet Excision System to target and excise aortic valve leaflets and mitigate risks during redo TAVR, StΓ½ri steering catheters, Viking RF Excision Catheter, and HemoShield temporary valve.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Excision Medical company profile β
Interrad Medical
HQ: United States
Website
- Description: Provider of innovative medical devices for minimally invasive interventional and surgical procedures, including SecurAcath, a subcutaneous anchoring device that secures peripherally inserted central catheters (PICCs) and other central venous catheters (CVCs), reducing the risk of catheter migration and dislodgement.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Interrad Medical company profile β
π
2.M&A buyers
2.1 Potential strategic acquirers in the sector
π
π
π
π
View all strategic buyers with complete profiles
Start Free Trial β
2.2 - Strategic buyer groups for InterVene
π
Buyer group 1: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 2: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 3: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial β
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to InterVene
2.2 - Growth funds investing in similar companies to InterVene
π
View all growth equity funds with complete profiles
Start Free Trial β
4 - Top valuation comps for InterVene
4.2 - Public trading comparable groups for InterVene
π Unlock all public trading comparable groups with complete valuation data
Start Free Trial β